Gallobe, Sheryll .

HRN: 11-61-40  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/20/2022
CEFUROXIME 750MG (VIAL)
09/20/2022
09/27/2022
IV
750mg
Q8
Post OP Prophylaxis
09/21/2022
CEFUROXIME 500MG (TAB)
09/21/2022
09/27/2022
PO
500MG
BID
S/P LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: